|
Index of reports
> Cases with Pyrexia (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cellcept (Mycophenolate Mofetil) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cellcept side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 56 year old female
Reactions: Chills, Hypotension, Pulmonary Oedema, Pleural Effusion, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sprycel
Dosage: interrupted and then restarted on 30 or 31jun11 with 70mg bid
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-02-01
Tacrolimus
Cellcept
Start date: 2011-01-01
Other drugs received by patient: Synthroid
Possible Cellcept side effects in male
Reported by a lawyer from Denmark on 2012-08-03
Patient: male
Reactions: Quality of Life Decreased, Parkinson's Disease, Cognitive Disorder, Pyrexia, Pneumocystis Jiroveci Pneumonia, Fatigue, Balance Disorder, Cerebral Thrombosis, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cellcept
Indication: Prophylaxis Against Transplant Rejection
Start date: 2006-11-06
Neoral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2006-11-06
Possible Cellcept side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain, Vomiting, Nausea, Pyrexia, Leukocytosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cellcept
Dosage: 1,000 mg bid po
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-05-25
Nulojix
Dosage: 841 mg q 4 weeks iv
Indication: Renal Transplant
Start date: 2012-06-21
Other drugs received by patient: Alentuzumab; Prednisone; Solu-Medrol
Possible Cellcept side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09
Patient: male, weighing 64.0 kg (140.8 pounds)
Reactions: Hepatitis B Antibody Positive, Epstein-Barr Virus Infection, Post Transplant Lymphoproliferative Disorder, Primary Mediastinal Large B-Cell Lymphoma, Cytomegalovirus Test Positive, Blood Uric Acid Increased, Cytomegalovirus Infection, Pyrexia, Hepatic Neoplasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simulect
Dosage: 20 mg, once/single
Start date: 2007-05-20
End date: 2007-05-20
Cellcept
Dosage: 1500 mg/day
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-17
Neoral
Dosage: 500 mg/day
Administration route: Oral
Indication: Renal Transplant
Start date: 2007-05-13
End date: 2007-05-23
Simulect
Dosage: 20 mg, once/single
Indication: Renal Transplant
Start date: 2007-05-16
End date: 2007-05-16
Other drugs received by patient: Sandimmune; Cinalong; Diovan; Solu-Medrol; Zyloric ^fresenius^; Prednisolone; Prednisolone; Allopurinol
Possible Cellcept side effects in female
Reported by a physician from Spain on 2012-06-15
Patient: female, weighing 63.5 kg (139.7 pounds)
Reactions: Urinary Tract Infection Enterococcal, Urinary Tract Infection, Cytomegalovirus Infection, Pyrexia, Lung Infiltration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cellcept
Dosage: current dose: 2000 mg
Cellcept
Dosage: previous dose was 3000 mg
Indication: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Cellcept
Cellcept
Cellcept
Other drugs received by patient: Prednisone TAB; Prednisone TAB; Pravastatin; Amlodipine Besylate; Lorazepam; Prednisone TAB; Nitroglycerin; Omeprazole; Clopidogrel; Bisoprolol Fumarate; Enalapril; Aspirin; Azathioprine; Citalopram Hydrobromide; Prednisone TAB; Azathioprine; Enoxaparin; Alendronate Sodium; Cotrim; Prednisone TAB; Furosemide; Calcium / Vitamin D
Possible Cellcept side effects in female
Reported by a physician from Japan on 2012-06-08
Patient: female
Reactions: Abdominal Pain, Lymphadenopathy, Snoring, Laryngeal Oedema, Pyrexia, Pericardial Effusion, Hypercholesterolaemia, C-Reactive Protein Increased, Heart Transplant Rejection, Laryngeal Neoplasm, Cardiac Hypertrophy, White Blood Cell Count Increased, Pneumonia, Vomiting, Post Transplant Lymphoproliferative Disorder, Brain Natriuretic Peptide Increased, Diarrhoea, Bronchitis, Myocardial Oedema, Obstructive Airways Disorder, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prograf
Dosage: 2 mg, unk
Administration route: Oral
Start date: 2005-02-28
End date: 2005-03-13
Certican
Dosage: unk
Start date: 2007-08-06
Prograf
Dosage: 2.8 mg, unk
Administration route: Oral
Start date: 2005-03-14
Cellcept
Dosage: 125 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2004-08-02
Certican
Dosage: 1.5 mg, unk
Administration route: Oral
Start date: 2005-03-04
End date: 2005-05-16
Certican
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Heart Transplant
Start date: 2005-02-21
Tacrolimus
Indication: Heart Transplant
Certican
Dosage: 1 mg, qd
Administration route: Oral
Start date: 2005-02-28
End date: 2005-03-03
Certican
Dosage: unk
Start date: 2007-02-20
Prograf
Dosage: 3.6 mg, unk
Administration route: Oral
Indication: Heart Transplant
End date: 2005-02-27
Prednisolone
Dosage: 2 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2001-05-01
Other drugs received by patient: Rituximab; Cotrim; Polygam S / D; Prednisolone; Enalapril Maleate
Possible Cellcept side effects in female
Reported by a physician from Japan on 2012-06-07
Patient: female, weighing 13.0 kg (28.6 pounds)
Reactions: Nasopharyngitis, Nausea, Pyrexia, Respiratory Syncytial Virus Infection, Renal Impairment, Diarrhoea, Interstitial Lung Disease, Heart Transplant Rejection, Rash Erythematous, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prograf
Dosage: 4.5 mg, unk
Administration route: Oral
Start date: 2006-01-23
End date: 2006-02-16
Certican
Dosage: 1 mg, unk
Administration route: Oral
Start date: 2006-01-30
End date: 2006-02-03
Certican
Dosage: 0.75 mg, unk
Administration route: Oral
Start date: 2006-02-03
End date: 2006-04-24
Certican
Dosage: 0.5 mg, unk
Administration route: Oral
Indication: Heart Transplant
Start date: 2006-01-23
End date: 2006-01-30
Neoral
Indication: Heart Transplant
Cellcept
Administration route: Oral
Indication: Heart Transplant
Start date: 2009-02-01
Certican
Dosage: 1 mg, daily
Administration route: Oral
Start date: 2008-01-23
End date: 2009-01-22
Azathioprine
Administration route: Oral
Indication: Heart Transplant
Tacrolimus
Indication: Heart Transplant
Prograf
Dosage: 4.8 mg, unk
Administration route: Oral
Indication: Heart Transplant
End date: 2006-01-23
Prograf
Dosage: 4.0 mg, unk
Administration route: Oral
Start date: 2006-03-20
End date: 2006-04-24
Certican
Dosage: unk
Administration route: Oral
End date: 2009-02-05
Certican
Dosage: unk
Prograf
Dosage: 3.0 mg, unk
Administration route: Oral
Start date: 2006-02-16
End date: 2006-03-20
Other drugs received by patient: Everolimus; Tenormin; Sirolimus; Famotidine
Possible Cellcept side effects in
Reported by a individual with unspecified qualification from Germany on 2012-05-29
Patient:
Reactions: Abdominal Pain, Respiratory Disorder, Diabetes Mellitus, Pulmonary Embolism, Cytomegalovirus Viraemia, Pyrexia, Cardiac Disorder, Musculoskeletal Disorder, Oedema, Procedural Complication, Injury, Thrombocytopenia, Anaemia, Urinary Tract Infection, Transplant Rejection, Lymphocele, Hyperlipidaemia, Hepatobiliary Disease, Diarrhoea, Impaired Healing, BK Virus Infection, Nervous System Disorder, Treatment Failure, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Sirolimus
Cyclophosphamide
Dosage: dose reported as 200-250 ng/ml
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Cellcept
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Cyclophosphamide
Dosage: csa was reduced by 50% and eliminated 3 days later.
Administration route: Oral
Sirolimus
Dosage: dose reported: 8-12 (-m3)5-10 (-m12) ng/ml. loading dose.
Indication: Prophylaxis Against Transplant Rejection
Cellcept
Dosage: after randomization.
Administration route: Oral
Other drugs received by patient: Immune Globulin (Human); Methylprednisolone; Methylprednisolone; Methylprednisolone; Methylprednisolone; Methylprednisolone
Possible Cellcept side effects in
Reported by a physician from Germany on 2012-05-29
Patient:
Reactions: Renal Cell Carcinoma, Abdominal Pain, Respiratory Disorder, Diabetes Mellitus, Cytomegalovirus Viraemia, Pyrexia, Cardiac Disorder, Pneumocystis Jiroveci Pneumonia, Musculoskeletal Disorder, Oedema, Procedural Complication, Injury, Thrombocytopenia, Hypertonia, Colon Cancer, Anaemia, Urinary Tract Infection, Transplant Rejection, Lymphocele, Hyperlipidaemia, Nasal Cavity Cancer, Hepatobiliary Disease, Diarrhoea, Impaired Healing, Nervous System Disorder, non-Hodgkin's Lymphoma, Treatment Failure, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclosporine
Dosage: dose reported as 150-200 (-m3) 100-150 (-m12) ng/ml. dosage lowered.
Administration route: Oral
Cellcept
Dosage: after randomization
Administration route: Oral
Cyclosporine
Dosage: dose reported as 200-250 ng/ml
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Cellcept
Dosage: 2-3 gram per day
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Other drugs received by patient: Anti-Thymocyte Globulin NOS; Methylprednisolone; Methylprednisolone; Methylprednisolone; Methylprednisolone; Methylprednisolone
Possible Cellcept side effects in 46 year old male
Reported by a physician from Japan on 2011-12-29
Patient: 46 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Pyrexia, Oropharyngeal Pain, Upper Respiratory Tract Inflammation, Hyperuricaemia, Oral Candidiasis, Nocardiosis, Serratia Test Positive, Asymptomatic Bacteriuria, Neurogenic Bladder, Urinary Tract Infection, Anaemia, Procedural Hypertension, Viral Upper Respiratory Tract Infection, Cytomegalovirus Chorioretinitis, Meningitis Cryptococcal, Cytomegalovirus Infection, Infection in AN Immunocompromised Host
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Prograf
Dosage: 3 mg, bid, oral
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2006-07-18
Prednisolone
Dosage: 5;20 mg, unknown/d, oral
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2006-07-15
Cellcept
Dosage: 500;250 mg, unknown d, oral
Administration route: Oral
Indication: Immunosuppressant Drug Therapy
Start date: 2006-07-12
Other drugs received by patient: Metoprolol Tartrate; Lansoprazole; Antifungals; Zantac; Diflucan; Basiliximab (Basiliximab); Amphotericin B; Ganciclovir; Fluconazole; Allopurinol; Amlodipine Besylate; Micardis; Ferromia (Ferrous Sodium Citrate); Urief (Silodosin); Avapro
|
